These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17886338)

  • 21. Natural killer cells: detectors of stress.
    Luci C; Tomasello E
    Int J Biochem Cell Biol; 2008; 40(11):2335-40. PubMed ID: 18595768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment.
    Urbani S; Amadei B; Tola D; Pedrazzi G; Sacchelli L; Cavallo MC; Orlandini A; Missale G; Ferrari C
    J Hepatol; 2008 Apr; 48(4):548-58. PubMed ID: 18280607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mission poorly accomplished: the protective role of natural killer cells in recurrent hepatitis C after liver transplantation.
    Zein NN
    Liver Transpl; 2008 Jan; 14(1):4-6. PubMed ID: 18161796
    [No Abstract]   [Full Text] [Related]  

  • 24. Pretransplantation CD56(+) innate lymphocyte populations associated with severity of hepatitis C virus recurrence.
    Rosen HR; Doherty DG; Madrigal-Estebas L; O'Farrelly C; Golden-Mason L
    Liver Transpl; 2008 Jan; 14(1):31-40. PubMed ID: 18161829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic and natural killer cells cooperate in the control/switch of innate immunity.
    Zitvogel L
    J Exp Med; 2002 Feb; 195(3):F9-14. PubMed ID: 11828015
    [No Abstract]   [Full Text] [Related]  

  • 26. Co-ordinating innate and adaptive immunity to viral infection: mobility is the key.
    Christensen JE; Thomsen AR
    APMIS; 2009 May; 117(5-6):338-55. PubMed ID: 19400861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic hepatitis C in the advanced adult and elderly subjects.
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Petraccaro M
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):145-57. PubMed ID: 19305374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infection.
    Ciesek S; Liermann H; Hadem J; Greten T; Tillmann HL; Cornberg M; Aslan N; Manns MP; Wedemeyer H
    J Viral Hepat; 2008 Mar; 15(3):200-11. PubMed ID: 18233993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cancer Immunotherapy by coordinated stimulation of innate lymphocytes (NK and NKT cells).
    Fujii S
    Rinsho Ketsueki; 2009 May; 50(5):364-74. PubMed ID: 19483396
    [No Abstract]   [Full Text] [Related]  

  • 32. The NKT cell system: bridging innate and acquired immunity.
    Taniguchi M; Seino K; Nakayama T
    Nat Immunol; 2003 Dec; 4(12):1164-5. PubMed ID: 14639465
    [No Abstract]   [Full Text] [Related]  

  • 33. Mistaken notions about natural killer cells.
    Yokoyama WM
    Nat Immunol; 2008 May; 9(5):481-5. PubMed ID: 18425104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killers and beyond: NK-cell-mediated control of immune responses.
    Andoniou CE; Coudert JD; Degli-Esposti MA
    Eur J Immunol; 2008 Nov; 38(11):2938-42. PubMed ID: 18979519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Killer dendritic cells and their potential role in immunotherapy.
    Ullrich E; Chaput N; Zitvogel L
    Horm Metab Res; 2008 Feb; 40(2):75-81. PubMed ID: 18283624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How to restore normal innate antitumor immunity in acute leukemia?
    Costello RT
    Leuk Res; 2009 May; 33(5):613. PubMed ID: 18952282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular physiopathology of viral hepatitis].
    Hayashi N; Kanto T; Hosui A; Sugimoto Y; Okawa K; Takehara T; Sasaki Y
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91 Suppl():89-93. PubMed ID: 12577933
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of innate and adaptive immunity on rejection and tolerance.
    Kim IK; Bedi DS; Denecke C; Ge X; Tullius SG
    Transplantation; 2008 Oct; 86(7):889-94. PubMed ID: 18852649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.